R Douglas Bruce, MD, MA, MSc

From academics to public/community health, Dr. Bruce has worked to develop and implement research and public health interventions both locally and internationally. Dr. Bruce is a global expert in substance use disorders among people with HIV/hepatitis C and serves as the substance use team lead for the Department of Health and Human Services Antiretroviral Guideline committee. From drug-drug interaction work to ascertain the impact of HIV and HCV therapeutics on methadone/buprenorphine and operations research to improve HIV/HCV and tuberculosis care, he has translated research into the clinical environments to improve outcomes for marginalized populations and reduce health disparities. Dr. Bruce has provided technical assistance to the CDC, United Nations, USAID, and non-governmental organizations to address HIV and substance use epidemics globally

In September 2020, Dr. Bruce moved to Boston to join Boston University School of Medicine and Boston Medical Center to continue practice transformation, innovation and quality improvement within a safety net organization’s large academic medical practice. Prior to that Dr. Bruce was the Chief of Medicine at Cornell Scott-Hill Health Center (CSHHC), where helped to transform the largest health center in New Haven with a focus on quality and value-based care which resulted in significant improvements in the delivery of clinical care, improvements in quality of care, and cost savings for CT Medicaid and the community. At the time of Dr. Bruce’s departure, the health center had generated over $4 million in savings for Connecticut Medicaid and was poised to assume operational control of the Internal Medicine and OB/GYN ambulatory practices and outpatient residency training of Yale New Haven Health. Prior to his role at CSHHC, Dr. Bruce was on the faculty of Yale School of Medicine in the Infectious Disease Section where he did research at the intersection of substance use disorders and infectious diseases.